Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Nat Commun ; 11(1): 3059, 2020 06 16.
Article in English | MEDLINE | ID: mdl-32546718

ABSTRACT

Autonomous replication and segregation of mitochondrial DNA (mtDNA) creates the potential for evolutionary conflict driven by emergence of haplotypes under positive selection for 'selfish' traits, such as replicative advantage. However, few cases of this phenomenon arising within natural populations have been described. Here, we survey the frequency of mtDNA horizontal transfer within the canine transmissible venereal tumour (CTVT), a contagious cancer clone that occasionally acquires mtDNA from its hosts. Remarkably, one canine mtDNA haplotype, A1d1a, has repeatedly and recently colonised CTVT cells, recurrently replacing incumbent CTVT haplotypes. An A1d1a control region polymorphism predicted to influence transcription is fixed in the products of an A1d1a recombination event and occurs somatically on other CTVT mtDNA backgrounds. We present a model whereby 'selfish' positive selection acting on a regulatory variant drives repeated fixation of A1d1a within CTVT cells.


Subject(s)
DNA, Mitochondrial/genetics , Dog Diseases/genetics , Haplotypes , Venereal Tumors, Veterinary/genetics , Animals , Dogs , Gene Transfer, Horizontal , Phylogeny , Polymorphism, Genetic , Recurrence , Selection, Genetic
2.
Science ; 365(6452)2019 08 02.
Article in English | MEDLINE | ID: mdl-31371581

ABSTRACT

The canine transmissible venereal tumor (CTVT) is a cancer lineage that arose several millennia ago and survives by "metastasizing" between hosts through cell transfer. The somatic mutations in this cancer record its phylogeography and evolutionary history. We constructed a time-resolved phylogeny from 546 CTVT exomes and describe the lineage's worldwide expansion. Examining variation in mutational exposure, we identify a highly context-specific mutational process that operated early in the cancer's evolution but subsequently vanished, correlate ultraviolet-light mutagenesis with tumor latitude, and describe tumors with heritable hyperactivity of an endogenous mutational process. CTVT displays little evidence of ongoing positive selection, and negative selection is detectable only in essential genes. We illustrate how long-lived clonal organisms capture changing mutagenic environments, and reveal that neutral genetic drift is the dominant feature of long-term cancer evolution.


Subject(s)
Clonal Evolution/genetics , Dog Diseases/classification , Dog Diseases/genetics , Venereal Tumors, Veterinary/classification , Venereal Tumors, Veterinary/genetics , Animals , Dog Diseases/epidemiology , Dogs , Exosomes , Gene Expression , Mutagenesis , Phylogeny , Selection, Genetic , Venereal Tumors, Veterinary/epidemiology
3.
Elife ; 52016 05 17.
Article in English | MEDLINE | ID: mdl-27185408

ABSTRACT

Canine transmissible venereal tumour (CTVT) is a clonally transmissible cancer that originated approximately 11,000 years ago and affects dogs worldwide. Despite the clonal origin of the CTVT nuclear genome, CTVT mitochondrial genomes (mtDNAs) have been acquired by periodic capture from transient hosts. We sequenced 449 complete mtDNAs from a global population of CTVTs, and show that mtDNA horizontal transfer has occurred at least five times, delineating five tumour clades whose distributions track two millennia of dog global migration. Negative selection has operated to prevent accumulation of deleterious mutations in captured mtDNA, and recombination has caused occasional mtDNA re-assortment. These findings implicate functional mtDNA as a driver of CTVT global metastatic spread, further highlighting the important role of mtDNA in cancer evolution.


Subject(s)
Dog Diseases/genetics , Genetic Variation , Mitochondria/genetics , Recombination, Genetic , Selection, Genetic , Venereal Tumors, Veterinary/genetics , Animals , DNA, Mitochondrial/chemistry , DNA, Mitochondrial/genetics , Dogs , Sequence Analysis, DNA
4.
Mov Disord ; 31(7): 1027-32, 2016 07.
Article in English | MEDLINE | ID: mdl-27028133

ABSTRACT

BACKGROUND: Fatigue is a common and debilitating nonmotor symptom of PD. Because preliminary evidence suggests that acupuncture improves fatigue in other conditions, we sought to test its efficacy in PD. METHODS: Ninety-four PD patients with moderate-to-high fatigue were randomized to receive 6 weeks of biweekly real or sham acupuncture. The primary outcome was change on the Modified Fatigue Impact Scale at 6 weeks. Secondary outcomes included sleep, mood, quality of life, and maintenance of benefits at 12 weeks. RESULTS: Both groups showed significant improvements in fatigue at 6 and 12 weeks, but with no significant between-group differences. Improvements from baseline in mood, sleep, and quality of life were noted without between-group differences. Overall, 63% of patients reported noticeable improvements in their fatigue. No serious adverse events were observed. CONCLUSIONS: Acupuncture may improve PD-related fatigue, but real acupuncture offers no greater benefit than sham treatments. PD-related fatigue should be added to the growing list of conditions that acupuncture helps primarily through nonspecific or placebo effects. © 2016 International Parkinson and Movement Disorder Society.


Subject(s)
Acupuncture Therapy/methods , Fatigue/therapy , Outcome Assessment, Health Care , Parkinson Disease/complications , Acupuncture Therapy/adverse effects , Aged , Fatigue/etiology , Female , Humans , Male , Middle Aged
6.
Arch Clin Neuropsychol ; 20(4): 517-29, 2005 Jun.
Article in English | MEDLINE | ID: mdl-15896564

ABSTRACT

Accurate understanding of practice characteristics, performance stability, and error on neuropsychological tests is essential to both valid clinical assessment and maximization of signal detection for clinical trials of cognitive enhancing drugs. We examined practice effects in 28 healthy adults. As part of a larger study using donepezil and simulating a Phase I trial, participants were randomized into: placebo, no-treatment and donepezil. Donepezil results are presented elsewhere. Neuropsychological tests were administered in a fixed order for 6 weeks, with alternate forms available for most tests. Despite alternate forms, ANOVAs revealed significant improvements for the pooled control group (placebo and no-treatment) on all tests except Letter Number Sequencing and Trails B. Learning occurred principally in the first three to four sessions. PASAT and Stroop interference showed the greatest learning. Thus, serial assessment with alternate forms may attenuate retest effects on some tests, but continued learning occurs on novel tests or those in which an advantageous test-taking strategy can be identified. Alternate forms and baseline practice sessions may help control early, rapid improvements in clinical trials.


Subject(s)
Indans/pharmacology , Neuropsychological Tests , Nootropic Agents/pharmacology , Piperidines/pharmacology , Practice, Psychological , Signal Detection, Psychological/drug effects , Adult , Donepezil , Double-Blind Method , Educational Status , Female , Humans , Male , Middle Aged , Reference Values , Reproducibility of Results , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...